Early dual antiplatelet therapy versus aspirin monotherapy after coronary artery bypass surgery: survival and safety outcomes
Autores da FMUP
Participantes de fora da FMUP
- Rocha-Gomes, JN
- Moreira, R
- Ferreira, AF
- Amorim, MJ
- Pinho, P
Unidades de investigação
Abstract
BACKGROUND: There is currently conflicting evidence regarding outcomes of dual antiplatelet therapy (DAPT) in patients following coronary artery bypass grafting (CABG). We aim to compare the survival and safety outcomes of DAPT versus aspirin (ASA) within a 24h window after CABG. METHODS : Single-center retrospective cohort study on consecutive patients undergoing 1st isolated CABG surgery in 2010. Survival analysis (median follow-up 9 years) was performed using Kaplan-Meier curves and multivariable Cox regression using propensity score (PS) as a covariate along with DAPT. Bleeding was assessed through red blood cells' (RBC) transfusion, re-exploration of thorax and drainage. RESULTS: We included 351 patients (251 were DAPT). Kaplan-Meier curves showed similar cumulative survival between groups (9y: 75% DA PT vs. 67% ASA, Log-rank P=0.103), as well as the PS adjusted analysis (HR DAPT: 0.93, 95% CI: 0.57-1.51). We found no differences in early mortality (2 DAPT and 1 ASA). Total median cell-saver transfusion (300 mL vs. 250 mL) and the re-exploration of thorax due to bleeding (1.6% vs. 4%) showed no statistical significance either. On the other hand, postoperative total median chest tube drainage was higher in the ASA group (1220 mL DAPT vs. 1320 mL ASA, P=0.034). There was also a lower frequency of DAPT patients requiring RBC transfusions (>= 3 units 4.8% vs. 13%, P=0.009, respectively). Redo-CABG was performed in 3 patients (2 DAPT vs. 1 ASA) during follow-up. CONCLUSIONS: Compared with ASA, DAPT showed a non-significant impact on long-term survival and demonstrated to be a safe option. Further studies are needed to provide recommendations on the therapeutical strategy following CABG.
Dados da publicação
- ISSN/ISSNe:
- 0021-9509, 1827-191X
- Tipo:
- Article
- Páginas:
- 662-672
- Link para outro recurso:
- www.scopus.com
Journal of Cardiovascular Surgery Edizioni Minerva Medica S.p.A.
Citações Recebidas na Web of Science: 2
Citações Recebidas na Scopus: 3
Documentos
- Não há documentos
Filiações
Keywords
- Coronary artery disease; Coronary artery bypass; Aspirin; Clopidogrel; Survival
Campos de estudo
Financiamento
Proyectos asociados
Estudo do tratamento da doença valvular aórtica.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Observacional Académico (AORTA) . UniC . 2019
Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (Ensaio AGTP II) . 2019
Citar a publicação
Rocha JN,Saraiva FA,Cerqueira RJ,Moreira R,Ferreira AF,Barros AS,Amorim MJ,Pinho P,Lourenço AP,Leite AF. Early dual antiplatelet therapy <i>versus</i> aspirin monotherapy after coronary artery bypass surgery: survival and safety outcomes. J. Cardiovasc. Surg. 2020. 61. (5):p. 662-672. IF:1,888. (3).